For too long there have been limited choices when it came to the use of chemotherapy for the treatment of cancer. At Reno Integrative Medical Center, we encourage cancer patients to consider a treatment called Insulin Potentiated Therapy or IPT as a viable, less toxic option to full dose chemotherapy. IPT targets the cancer cells rather than affecting the entire body. This is huge when one considers efficiency and recovery rate.
This therapy is not available in most states due to laws prohibiting it. We offer IPT at Reno Integrative Medical Center in Reno, Nevada, along with several other viable alternative treatments to treat cancer.
If you or someone you know, has been told they need to do full dose chemotherapy, you might want to learn more about IPT therapy. It targets the cancer while using a 10th of the dose. This therapy is far less toxic and far more efficient.
Reno Integrative Medical Center is one of few clinics in the United States that offers this therapy.
Cancer cells use anaerobic metabolism (burn sugar without using oxygen) to produce energy. The problem (for the cancer cell) is that this mechanism is 18 times less efficient than the aerobic (oxygen utilizing) metabolism that our normal cells use. That means the cancer cells need 18 times more sugar than normal cells to grow and prosper.
Insulin Potentiated Therapy takes advantage of the cancer cell’s weakness for the need of more sugar. It cannot go long without sugar and is actually quite weak and vulnerable under the right conditions. Cancer cells cannot skip breakfast and have a bigger lunch. They have to have a constant supply of energy to survive.
Drop the body’s blood sugar and they become desperate for food. They make sure they get their fuel first before healthy cells. It has also been proven that cancer cells have between 10 and 100 times the number of insulin receptors to better insure they get as much sugar as is possible. With IPT therapy, we surprise the desperate cancer cells with compounds that shut down their energy production without affecting normal cells.